broaden the horizon
Release time:
2020-08-14
Broad Vision
Recently, Song Xiaofei, director of the manufacturing workshop of Yunnan Jianfeng Cement Company, recommended a book-"Huawei Work Law" to the shift leaders.
Reading is the ladder of human progress. The book "Huawei Work Law" talks about the core working methods of Huawei 25 years. Based on the examples of Huawei's development process, Huawei's experience and Ren Zhengfei's own internal speech, this book tells Huawei's target management, work implementation, work principles and many other aspects, so that you can directly reach the essence and essence of the work. Whether it is grass-roots employees or managers, there are many things in the book that we can learn from. (Mao Jianling) Huang Jiwei, author of
Huawei Work Law
Huawei Work Law, is an executive trainer, organization development and talent training consultant. He graduated from the Central University of Finance and Economics, and later obtained a MBA degree from Duke University's Fuka Business School and a master's degree in humanities from the University of Chicago. He worked in a world-renowned consulting company and was promoted to a managing partner. For many years, he has devoted himself to studying Huawei's internal innovation and working mechanism, hoping to let more enterprises learn from Huawei's core working methods and promote the double growth of efficiency and efficiency.
Huawei is one of the most popular Chinese enterprises in recent years, and it is also famous in the world. In a short period of more than 20 years, Huawei has gradually grown from an unknown small enterprise to a leader in the communication equipment industry. From the beginning, a company that could only open up markets in rural areas and counties, Huawei has become a multinational company across Asia, Africa, Europe and other places. From a small company that started with a capital of 2 yuan, it has become a super company with an annual turnover of about 3000 .7 billion yuan.
The development of an enterprise or an individual ultimately depends on specific work. Whether these work can produce higher efficiency and whether employees can have better performance depends to a large extent on working methods and attitudes. The book "Huawei Work Law" lists a large number of cases in the development process of Huawei, as well as the experience of Huawei people and the conversation between Huawei President Ren Zhengfei, from the aspects of efficient execution, employees' subjective initiative, scientific and reasonable working principles, employees' working attitude, team cooperation, communication and exchange, self-improvement, happy work, etc, it focuses on Huawei's target management, work execution, work principles, and employees' work attitude. At the same time, through simple and popular theoretical interpretation and analysis, how to improve the work efficiency of employees; Why is the work always getting busier and busier? How to improve the execution of employees; Why is the management very strict, but it is always difficult to achieve the desired effect? How to improve the subjective initiative of employees; How to improve the competitiveness of enterprises and other issues to expand.
Many entrepreneurs are eager to build a Huawei-style company and want to have employees like Huawei. Many office workers also want to work like Huawei people and make outstanding achievements like Huawei people. Execution is an important indicator to measure the value and ability of work. Efficient execution is the ultimate productivity. Every employee should always strengthen and improve their execution and awareness of execution, focus, obey the distribution, do what should be done immediately, and maintain good discipline, so as to ensure a sustained leading edge in the competition. Efficient execution is one of the important factors for Huawei to go global.
The secret of enterprise success cannot be completely copied. Each enterprise has its own specific conditions and environment, but the various working methods of Huawei in the process of operation and the working attitude and methods of Huawei people are still worth learning from.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page